Stockscreener 앱 받기
2.38
0.42%
0.010
시간 외 거래:
2.36
-0.02
-0.84%
Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스
CCORF Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $7 - moomoo.com
Compass Therapeutics Inc. (CMPX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Compass (CMPX) Earnings Update: The EPS Result Is Below Expectation in the Current Update; After Earnings: Shares Finish 0.21% Higher on the DayProfit Cycle Analysis - vinanet.vn
CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update - Stocktwits
Compass (CMPX) Session: Finishes 4.23% Lower at $2.38; Technical Setup: the Supplied Trading Band Runs From $2.26 to $2.50 in the Current UpdateDollar Neutral Pair - vinanet.vn
NEXTBio Capital Management LP's Compass Therapeutics Inc(CMPX) Holding History - GuruFocus
Compass (CMPX) Earnings Data Review: The EPS Result Is Below Expectation in the Available Record; Investor Response: Shares Close 3.46% Higher in the Latest SessionCore Business Growth - vinanet.vn
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Stifel Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
We're Not Very Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Rate - Moomoo
Compass Therapeutics (CMPX) Climbs 3.26% to $2.22, Approaches Key ResistanceMoney Flow - dars.gov.et
HC Wainwright Issues Pessimistic Estimate for CMPX Earnings - MarketBeat
Compass Therapeutics Inc. (CMPX) Stock News Today - TradingKey
Compass Therapeutics (NASDAQ:CMPX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
A Quick Look at Today's Ratings for Compass Therapeutics(CMPX.US), With a Forecast Between $6 to $7 - Moomoo
Compass Therapeutics (NASDAQ:CMPX) Price Target Raised to $6.00 at Piper Sandler - MarketBeat
Compass Therapeutics Inc. (CMPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Compass Therapeutics (CMPX) Gains 4.5% to $2.08 as Buyers Defend Key Support LevelVWAP Deviation - vinanet.vn
Compass Therapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 359% Upside - TradingView
Compass Therapeutics, Inc. Q2 2026 Financial Results: Balance Sheet, Losses & Key Highlights from CMPX 10-Q Filing - Minichart
Form 8K Compass Therapeutics, Inc. For: 6 August By Investing.com - Investing.com Nigeria
Compass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - tradingview.com
Compass Therapeutics (NASDAQ: CMPX) details Q2 loss and BTC trial gains - stocktitan.net
CMPX: Strong pipeline progress and solid cash position support continued clinical development - TradingView
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update - Yahoo Finance
Compass Therapeutics, Inc. (CMPX) Investigation: Bronstein, Gewir - The National Law Review
Compass Therapeutics (CMPX) Projected to Announce Earnings on Monday - MarketBeat
Compass Therapeutics Inc. (CMPX) Institutional Confidence - TradingKey
CMPX Q2'26 Earnings: revenue estimate is (600.00K USD) - TradingView
CMPX|Compass Therapeutics Inc.|Price:2.360|Chg%:-0.120 - TradingKey
Compass Therapeutics, Inc. $CMPX Shares Sold by Rock Springs Capital Management LP - MarketBeat
Compass Therapeutics Inc. (CMPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Compass Therapeutics Inc. (CMPX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Compass Therapeutics Inc. (CMPX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Compass Therapeutics Inc. (CMPX) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
CMPX|Compass Therapeutics Inc.|Price:2.080| - TradingKey
TradingKey - TradingKey
Compass Therapeutics Inc. (CMPX) Income Statement - TradingKey
Compass Therapeutics Inc. (CMPX) Balance Sheet - TradingKey
CMPX|Compass Therapeutics Inc.|Price:2.092|Chg%:+0.022 - TradingKey
Compass Therapeutics, Inc. Revenue Breakdown – NASDAQ:CMPX - TradingView
CMPX Q1 2026 Earnings: Narrow EPS Beat as Clinical-Stage Biotech Continues Pipeline DevelopmentStrong Earnings Momentum - po-news-eg.net
Compass Therapeutics Inc. (CMPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Monashee Investment Management LLC Sells 741,135 Shares of Compass Therapeutics, Inc. $CMPX - MarketBeat
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Compass Therapeutics (CMPX) Slides 2.38% as Support Levels Come Into FocusLong Setup Ideas - vinanet.vn
Enterprise value to EBIT forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView
Compass Therapeutics (CMPX) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Compass Therapeutics to present Phase 2/3 tovec... - Pluang
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 - The Manila Times
Compass Therapeutics’ COMPANION-002 Biliary Tract Cancer Study Accepted for Oral Presentation at ESMO 2026 - Quiver Quantitative
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity - Seeking Alpha
0.86%
0.31%
자본화:
|
볼륨(24시간):